Orchard Therapeutics PLC (ORTX)
NASDAQ:ORTX
Holding ORTX?
Track your performance easily

Orchard Therapeutics (ORTX) Stock Forecast & Price Target

1,688 Followers
See the Price Targets and Ratings of:

ORTX Analyst Ratings

Currently, no data available
Based on 0 analysts giving stock ratings to
Orchard
Therapeutics
in the past 3 months
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers​ in the past 3 months

ORTX Stock 12 Month Forecast

There Are No Analyst Ratings for ORTX In The Last 3 Months.
Highest Price TargetAverage Price TargetLowest Price Target
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

ORTX Financial Forecast

No data currently available

ORTX Earnings Forecast

Currently, no earnings data available.
Currently, no earnings data available.
No data currently available

ORTX Sales Forecast

Currently, no sales data available.
Currently, no sales data available.

Detailed List of Analyst Forecasts​

Ranks
Any
Any
Analyst Rating
Any
Any
Upside/ Downside
Any
Any
Action
Any
Any
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
Stifel Nicolaus
$16
Hold
-4.19%
Downside
Downgraded
10/05/23
Orchard Therapeutics downgraded to Hold from Buy at StifelOrchard Therapeutics downgraded to Hold from Buy at Stifel
Cantor Fitzgerald
$15
Buy
-10.18%
Downside
Initiated
06/26/23
Orchard Therapeutics (ORTX) Gets a Buy from Cantor Fitzgerald - TipRanks.comCantor Fitzgerald analyst Pete Stavropoulos reiterated a Buy rating on Orchard Therapeutics ( ORTX Research Report) today and set a price target of $15.00. The companys shares opened today at $5.30.
Oppenheimer
$34
Buy
103.59%
Upside
Reiterated
06/13/23
Orchard Therapeutics (ORTX) PT Lowered to $34 at OppenheimerOppenheimer analyst Hartaj Singh lowered the price target on Orchard Therapeutics (NASDAQ: ORTX) to $34.00 (from $37.00) while maintaining a Outperform rating.

Best Analysts Covering Orchard Therapeutics

Which Analyst Should I Follow If I Want to Buy ORTX and Sell After:
1 Month
xxx
Success Rate
2/3 ratings generated profit
67%
Average Return
-0.20%
reiterated a xxx
rating a year ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 1 Month would result in 66.67% of your transactions generating a profit, with an average return of -0.20% per trade.
3 Months
xxx
Success Rate
2/3 ratings generated profit
67%
Average Return
-7.43%
reiterated a xxx
rating a year ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 3 Months would result in 66.67% of your transactions generating a profit, with an average return of -7.43% per trade.
1 Year
Hartaj SinghOppenheimer
Success Rate
2/3 ratings generated profit
67%
Average Return
+152.87%
reiterated a buy rating a year ago
Copying Hartaj Singh's trades and holding each position for 1 Year would result in 66.67% of your transactions generating a profit, with an average return of +152.87% per trade.
2 Years
xxx
Success Rate
3/3 ratings generated profit
100%
Average Return
+218.10%
reiterated a xxx
rating a year ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 2 Years would result in 100.00% of your transactions generating a profit, with an average return of +218.10% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

ORTX Analyst Recommendation Trends

Rating
Jul 22
Mar 23
Jun 23
Oct 23
Jan 24
Strong Buy
2
4
6
5
2
Buy
1
1
0
0
0
Hold
0
0
0
1
2
Sell
0
0
0
0
0
Strong Sell
0
0
0
0
0
total
3
5
6
6
4
In the current month, ORTX has received 2 Buy Ratings, 2 Hold Ratings, and 0 Sell Ratings. ORTX average Analyst price target in the past 3 months is .
Each month's total comprises the sum of three months' worth of ratings.
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

ORTX Stock Forecast FAQ

What is ORTX’s average 12-month price target, according to analysts?
Currently, no data Available
What is ORTX’s upside potential, based on the analysts’ average price target?
Currently there's no upside potential for ORTX, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
    How can I follow the stock ratings of top Wall Street analysts?
    Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
      Is ORTX a Buy, Sell or Hold?
      Currently, no data Available
      What is Orchard Therapeutics PLC’s price target?
      Currently, no data Available
      What do analysts say about Orchard Therapeutics PLC?
      Not enough analysts have published a price target to provide an average price target.
      How can I buy shares of ORTX?
      Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.
        What am I Missing?
        Make informed decisions based on Top Analysts' activity
        Know what industry insiders are buying
        Get actionable alerts from top Wall Street Analysts
        Find out before anyone else which stock is going to shoot up
        Get powerful stock screeners & detailed portfolio analysis